GLP-1 agonists, which include Ozempic, may provide support in the treatment of type 1 diabetes. (Image credit: Tatyana Volkava via Getty Images)
Ozempic's active ingredient, semaglutide, along with other drugs in this class, has made significant changes in the treatment of obesity and type 2 diabetes. New clinical studies show that these drugs may also be effective in type 1 diabetes.
The study, published June 23 in the journal NEJM Evidence, suggests that semaglutide may help raise blood sugar levels and promote weight loss in people with type 1 diabetes, potentially opening the door to using the drug in combination with insulin to treat the condition.
“For a hundred years, we’ve focused on insulin and insulin delivery… there really aren’t any additional drugs approved for type 1,” lead study author Dr. Viral Shah, a diabetes researcher at Indiana University, told Live Science. There are some additional drugs that can be used in conjunction with insulin, but Shah sees drugs like Ozempic as a potential option for primary therapy.
You may like
-
Experimental pill 'Ozempic' shows promise in treating type 2 diabetes
-
Drug cuts migraine days in half in early trial – and may work through 'completely new mechanism'
Sourse: www.livescience.com
